A B Gottlieb Selected Research

OKT4A monoclonal antibody

10/2000

Anti-CD4 monoclonal antibody treatment of moderate to severe psoriasis vulgaris: results of a pilot, multicenter, multiple-dose, placebo-controlled study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A B Gottlieb Research Topics

Disease

42	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2021 - 05/2000
10	Necrosis 12/2021 - 06/2001
6	Psoriatic Arthritis 12/2021 - 01/2003
3	Infections 10/2015 - 06/2005
2	Herpes Zoster 01/2019 - 10/2015
2	Inflammation (Inflammations) 10/2015 - 02/2013
2	Autoimmune Diseases (Autoimmune Disease) 09/2015 - 09/2000
2	Fatigue 05/2008 - 12/2007
1	Hidradenitis Suppurativa 01/2019
1	Pruritus (Itching) 12/2015
1	Hyperplasia 10/2015
1	Stroke (Strokes) 10/2015
1	Infectious Arthritis (Septic Arthritis) 10/2015
1	Epiglottitis 10/2015
1	Melanoma (Melanoma, Malignant) 10/2015
1	Disease Progression 09/2015
1	Vitiligo 09/2015
1	Skin Diseases (Skin Disease) 04/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2013
1	Neoplasms (Cancer) 10/2013
1	Dizziness (Lightheadedness) 05/2008
1	Hepatitis C 12/2003
1	Ankylosing Spondylitis 12/2003
1	Rheumatoid Arthritis 12/2003
1	Immune System Diseases (Immune Disorders) 01/2003
1	Scalp Dermatoses 07/2001
1	Acne Vulgaris 11/2000
1	Chronic Disease (Chronic Diseases) 10/2000
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2000

Drug/Important Bio-Agent (IBA)

11	Monoclonal AntibodiesIBA 01/2019 - 05/2000
8	Etanercept (Enbrel)FDA Link 12/2021 - 01/2003
6	Certolizumab Pegol FDA Link 01/2021 - 07/2012
6	Prostaglandins AIBA 03/2019 - 06/2001
6	Infliximab (Remicade)FDA Link 09/2015 - 05/2000
5	secukinumabIBA 12/2021 - 12/2014
4	Interleukin-12 (IL 12)IBA 12/2021 - 09/2011
4	Biological ProductsIBA 12/2021 - 05/2008
3	Adalimumab (Humira)FDA Link 12/2021 - 04/2015
3	Interleukin-17 (Interleukin 17)IBA 12/2021 - 08/2016
3	ixekizumabIBA 10/2018 - 03/2017
3	brodalumabIBA 08/2018 - 08/2016
3	CytokinesIBA 08/2016 - 09/2015
3	Pharmaceutical PreparationsIBA 10/2015 - 01/2003
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2003 - 05/2000
2	Ustekinumab (CNTO 1275)FDA Link 12/2021 - 01/2018
2	InterleukinsIBA 12/2021 - 10/2015
2	Biological FactorsIBA 01/2021 - 01/2021
2	tofacitinibIBA 01/2019 - 10/2015
2	Janus Kinase InhibitorsIBA 01/2019 - 10/2015
2	Antirheumatic Agents (DMARD)IBA 12/2018 - 12/2018
2	apremilastIBA 12/2015 - 05/2008
2	Immunoglobulin G (IgG)IBA 10/2015 - 05/2008
2	Immunoglobulin A (IgA)IBA 02/2015 - 12/2014
2	briakinumabIBA 10/2013 - 09/2011
2	Alefacept (Amevive)FDA Link 11/2005 - 01/2003
2	RetinoidsIBA 10/2001 - 11/2000
1	Interleukin-17 ReceptorsIBA 08/2018
1	Phosphodiesterase 4 InhibitorsIBA 12/2015
1	Interleukin-23 Subunit p19IBA 10/2015
1	ruxolitinibIBA 10/2015
1	Keratin-16 (Keratin 16)IBA 10/2015
1	tildrakizumabIBA 10/2015
1	Tumor Necrosis Factor InhibitorsIBA 09/2015
1	omega-Chloroacetophenone (Mace)IBA 10/2013
1	Proteins (Proteins, Gene)FDA Link 02/2013
1	Transcription Factors (Transcription Factor)IBA 02/2013
1	NF-kappa B (NF-kB)IBA 02/2013
1	Methotrexate (Mexate)FDA LinkGeneric 09/2012
1	Fluocinolone Acetonide (Capex)FDA LinkGeneric 05/2008
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 05/2008
1	Ointments (Pastes)IBA 05/2008
1	efalizumab (Raptiva)FDA Link 05/2008
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 05/2008
1	pimecrolimus (Elidel)FDA Link 06/2005
1	Calcineurin InhibitorsIBA 06/2005
1	Ficusin (Psoralen)IBA 10/2001
1	Immunologic Factors (Immunomodulators)IBA 10/2001
1	Acitretin FDA Link 10/2001
1	Betamethasone Valerate (Betamethasone 17 Valerate)FDA LinkGeneric 07/2001
1	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2001
1	Vitamin E FDA LinkGeneric 11/2000
1	Isotretinoin (Accutane)FDA LinkGeneric 11/2000
1	OKT4A monoclonal antibodyIBA 10/2000
1	Interleukin-2 (IL2)IBA 09/2000
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 09/2000
1	Daclizumab (Zenapax)FDA Link 09/2000

Therapy/Procedure

13	Therapeutics 01/2019 - 05/2000
3	Biological Therapy 03/2019 - 05/2008
1	Retreatment 04/2015
1	Aftercare (After-Treatment) 04/2015
1	Subcutaneous Injections 02/2015
1	Phototherapy (Light Therapy) 10/2001